Board Meeting6 May 2026, 07:41 pm
Mangalam Drugs Board Meeting on May 14, 2026
AI Summary
Mangalam Drugs & Organics Ltd has announced a Board of Directors meeting scheduled for May 14, 2026, to consider and approve the audited financial results (standalone & consolidated) for the quarter and year ended March 31, 2026. The trading window for dealing in the company's securities has been closed for Directors/Officers and designated employees from April 1, 2026, and will remain closed until 48 hours after the announcement of the audited financial results.
Key Highlights
- Board meeting scheduled for May 14, 2026, to approve audited financial results.
- Financial results are for the quarter and year ended March 31, 2026.
- Trading window closed from April 1, 2026, until 48 hours post-results announcement.
- Closure of trading window informed to designated persons.
Price Impact
More from MANGALAM